10.23.07Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients with Urea Cycle Disorders
10.4.07Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
9.5.07Hyperion Therapeutics Secures $40 Million in Series B Round
8.28.07Medicis and Hyperion Therapeutics Announce Strategic Collaboration
Recent Press Releases